The U.S. Food and Drug Administration (FDA) has formally warned Dayan Goodenowe, founder of the Dr. Goodenowe Restorative Health Center in Moose Jaw, Saskatchewan, over a...
In a significant advancement for Alzheimer’s treatment, Sharon Runge has become the first patient in Canada to receive an infusion of Lecanemab, a drug recently approved...
Sharon Runge has made history as the first patient in Canada to receive an infusion of Lecanemab, a newly approved Alzheimer’s treatment. This milestone follows the...
Sharon Runge has made history as the first patient in Canada to receive an infusion of Lecanemab, a newly approved drug aimed at fighting Alzheimer’s disease....
A groundbreaking study suggests that Alzheimer’s disease may not only be preventable but could potentially be reversed. The research, led by Dr. Dale Bredesen at The...
The ongoing debate surrounding Medical Assistance in Dying (MAID) has taken a significant turn as advocates are urging for a reevaluation of its advance approval for...
Recent discussions surrounding the advance approval of Medical Assistance in Dying (MAID) for individuals diagnosed with Alzheimer’s disease have sparked significant debate. Advocacy groups and health...
New research highlights the evolving capabilities of blood tests to detect biomarkers associated with Alzheimer’s disease. As scientists strive to create accessible, early warning systems for...
Recent advancements in blood testing for Alzheimer’s disease have generated optimism among researchers and healthcare professionals. New studies indicate that tracking changes in specific protein biomarkers...
Research into blood tests for Alzheimer’s disease is advancing at a rapid pace, showing promise for early detection of the condition. Recent studies reveal that monitoring...
